Vision Innovation Partners (VIP) is expanding its presence in Maryland with the acquisition of Frederick Eye Institute, a move that bolsters the platform’s network of eye care providers and addresses growing demand for specialized services in the Frederick community. The deal, announced March 30, 2026, marks VIP’s 28th add-on since its founding in 2017 and signals continued investment in the Mid-Atlantic region’s ophthalmology market.
The acquisition brings Dr. Robert Bruce Hodges, a board-certified eye physician and surgeon and his practice’s expertise in cataract surgery, lens implants, and treatment for conditions like glaucoma and macular degeneration into the VIP fold. This expansion is particularly significant as the demand for high-quality eye care continues to rise, according to VIP CEO Chris Moore.
“The demand for high-quality eye care in the Frederick community keeps growing, and Dr. Hodges has done an outstanding job stepping up to meet that need,” Moore stated. “By bringing Frederick Eye Institute into our network, we can provide the operational infrastructure required to support a busy, highly-respected practice. Partnering with a surgeon of his caliber not only expands patient access to state-of-the-art care but also reinforces our continued commitment to growing our premier vision care footprint throughout Maryland and the greater Mid-Atlantic region.”
Dr. Hodges echoed this sentiment, emphasizing the importance of maintaining personalized care amidst a growing patient base. “We have experienced a significant influx of new patients recently, and maintaining our high standard of personalized care is my absolute top priority,” he said. “VIP’s support will allow us to efficiently accommodate our growing patient base and provide exceptional, uninterrupted clinical and surgical care to the Frederick community.”
Expanding VIP’s Footprint in the Mid-Atlantic
VIP, backed by private investment firm Gryphon Investors, has rapidly grown since its inception in 2017. The platform now encompasses 69 locations and 12 surgery centers across Maryland, Washington D.C., Virginia, Pennsylvania, and Delaware, serving over 150 providers. This latest acquisition underscores VIP’s strategy of partnering with leading ophthalmology practices to enhance service delivery and expand access to specialized care. Gryphon Investors has more than $10 billion in assets under management as of March 30, 2026, according to their website.
Frederick Eye Institute: A Focus on Advanced Care
Frederick Eye Institute has established itself as a key provider of comprehensive ophthalmological services in Frederick, Maryland. The practice specializes in a range of procedures, including cataract surgery and lens implants, utilizing advanced technology to treat conditions such as glaucoma, macular degeneration, cataracts, and dry eyes. They also offer routine eye exams, emphasizing preventative care. The institute’s commitment to utilizing the latest advancements in eye care technology positions it as a valuable addition to the VIP network.
The Role of Private Equity in Ophthalmology
The acquisition of Frederick Eye Institute is part of a broader trend of consolidation within the ophthalmology sector, driven in part by private equity investment. Firms like Gryphon Investors are actively acquiring and partnering with eye care practices, aiming to create larger, more efficient platforms. This consolidation can lead to increased investment in technology, expanded service offerings, and improved operational efficiency, but also raises questions about potential impacts on patient care and costs. According to a 2024 report by the American Academy of Ophthalmology, private equity-backed practices are growing at a rate of 15% annually, significantly outpacing independent practices.
The integration of Frederick Eye Institute into the VIP network is expected to be seamless, with a focus on preserving the practice’s commitment to patient care. VIP’s operational support is intended to alleviate administrative burdens and allow Dr. Hodges and his team to focus on delivering high-quality medical services. The company plans to leverage its existing infrastructure to streamline operations and enhance patient access.
Looking ahead, VIP is poised to continue its expansion throughout the Mid-Atlantic region, seeking additional opportunities to partner with leading ophthalmology practices. The company’s growth trajectory suggests a continued focus on building a comprehensive network of eye care providers, offering a wide range of services to meet the evolving needs of patients. The success of this strategy will depend on VIP’s ability to effectively integrate acquired practices while maintaining a commitment to quality and patient satisfaction.
What are your thoughts on the increasing consolidation in the healthcare industry? Share your comments below, and please share this article with your network.
